Small molecule mediated targeting provides alternative strategies for polypharmacology, systems biology and personalized medicine.

Most ongoing research and clinical programs have precision medicine at the core.

BBCR can assist in a number of areas in relation to precision medicine, including small molecule research, including:

• Strategic drug assessment
• Early Clinical Development
• Regulatory consultant
• FDA meeting and submission
• Pre-IND integrated development plan
• Clinical consultant
• Clinical study design and protocol
• CRO and project management
• Project remediation and rescue

Traditional small molecule drug development is a linear process, with little opportunity for feedback or improvement on the upstream components of the process from downstream results.

Personalized medicine offers advantages to the pharmaceutical industry by increasing efficiency and reduced costs of lead small molecule development, reducing timelines and costs of clinical trials, and generating differentiation in the marketplace.

Personalized medicine creates advantages to patients and clinicians with a higher probability of the desired outcome with target treatment, low probability of untoward side effects, focused therapies, better health, and better healthcare.

Learn More

Specializing in rare disease, Boston Biotech Clinical Research works with biotech, pharmaceutical, device companies and investors to streamline the clinical trial process. Our experienced team helps each client reach their specific goals by customizing a clinical and regulatory road map of simplified programs and streamlined protocols to meet our clients’ requirements.

"*" indicates required fields

NAME:*

EMAIL:*

PHONE NUMBER:

COMMENTS:*

CAPTCHA

Name

This field is for validation purposes and should be left unchanged.